Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Klinge discovers compounds for asthma with high efficacy and safety

Feb. 18, 1998

Olopatadine still under regulatory review in Japan

Feb. 18, 1998

Substance P antagonists revealed by Boehringer Ingelheim

Feb. 18, 1998

Dual inhibitors of PDE IV and TNF production prepared at Chiroscience

Feb. 17, 1998

Chiroscience describes series with PDE/TNF-inhibitory properties

Feb. 13, 1998

Byk Gulden describes new imidazopyridine PDE IV inhibitors

Feb. 12, 1998

Lilly describes second-generation NK1 antagonist

Feb. 11, 1998

Safety warnings issued by FDA for Hismanal

Feb. 11, 1998

PLA2 inhibitors --BM-16.2115, mepacrine and manoalide-- reduce human leukocyte chemotaxis

Feb. 11, 1998

Encouraging phase I results reported for Surfaxin in ARDS

Feb. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...